A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 17484712)

Published in Med J Aust on May 07, 2007

Authors

David C Risson1, Enda D O'Connor, Roger W Guard, Jacqueline M Schooneveldt, Graeme R Nimmo

Author Affiliations

1: Toowoomba Base Hospital, Toowoomba, Queensland, Australia.

Articles citing this

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82

Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol (2013) 1.34

Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol (2011) 1.12

Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model. Antimicrob Agents Chemother (2009) 1.02

The molecular epidemiology of the highly virulent ST93 Australian community Staphylococcus aureus strain. PLoS One (2012) 0.94

Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus. Genome Biol Evol (2014) 0.92

Community-associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol (2014) 0.84

Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton-Valentine leukocidin. Eur J Clin Microbiol Infect Dis (2010) 0.83

Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Med J Aust (2008) 0.83

Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Antimicrob Agents Chemother (2010) 0.82

Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung". Emerg Radiol (2008) 0.80

Prospective Analysis Methicillin-resistant Staphylococcus aureus and its Risk Factors. J Glob Infect Dis (2013) 0.77

Whole genome sequencing to investigate a putative outbreak of the virulent community-associated methicillin-resistant Staphylococcus aureus ST93 clone in a remote Indigenous community. Microb Genom (2016) 0.75

A Neonatal Murine Model of MRSA Pneumonia. PLoS One (2017) 0.75

Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection. Sci Rep (2017) 0.75

Articles by these authors

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83

Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis (2011) 3.06

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39

Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust (2009) 2.16

Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology (2013) 2.13

Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol (2004) 2.03

Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol (2006) 1.87

Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med J Aust (2011) 1.86

Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol (2009) 1.75

Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis (2003) 1.68

Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. J Clin Microbiol (2012) 1.48

Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol (2006) 1.38

Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis (2005) 1.35

Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust (2003) 1.30

Nematode symbiont for Photorhabdus asymbiotica. Emerg Infect Dis (2006) 1.26

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol (2010) 1.25

Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol (2007) 1.16

Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol (2008) 1.15

bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother (2005) 1.15

Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell Q Rep (2009) 1.08

Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests. J Clin Microbiol (2010) 1.03

Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J Clin Microbiol (2010) 1.00

Escherichia coli ST131 producing CTX-M-15 in Australia. J Antimicrob Chemother (2010) 1.00

Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med (2009) 0.97

mecA Locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone. J Clin Microbiol (2004) 0.90

Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS One (2013) 0.90

Post-exposure passive immunisation for preventing measles. Cochrane Database Syst Rev (2014) 0.89

Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Appl Environ Microbiol (2013) 0.88

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain. Viruses (2009) 0.88

Genotyping of methicillin-resistant Staphylococcus aureus by assaying for the presence of variable elements associated with mecA. J Clin Microbiol (2002) 0.86

Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infect Control Hosp Epidemiol (2010) 0.85

Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations. MBio (2014) 0.84

Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. J Antimicrob Chemother (2011) 0.84

Laboratory diagnosis of Clostridium difficile-associated diarrhoea: microbiologists (should) do it with culture. Pathology (2009) 0.84

Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome. Cochrane Database Syst Rev (2015) 0.84

Screening for H7N9 influenza A by matrix gene-based real-time reverse-transcription PCR. J Virol Methods (2013) 0.82

Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. J Med Virol (2007) 0.81

Molecular characterization of endocarditis-associated Staphylococcus aureus. J Clin Microbiol (2013) 0.81

A PCR method for the identification of methicillin-resistant Staphylococcus aureus (MRSA) from screening swabs. Pathology (2004) 0.80

Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep (2007) 0.79

Typing early Australian healthcare-associated MRSA: confirmation of major clones and emergence of ST1-MRSA-IV and novel ST2249-MRSA-III. Pathology (2013) 0.79

Bordetella holmesii and pertussis diagnosis: authors' reply. Pathology (2013) 0.79

Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in south-east Queensland. Med J Aust (2002) 0.79

Identification of Photorhabdus asymbiotica in cases of human infection. Commun Dis Intell Q Rep (2003) 0.78

Improved detection of genetic markers of antimicrobial resistance by hybridization probe-based melting curve analysis using primers to mask proximal mutations: examples include the influenza H275Y substitution. J Antimicrob Chemother (2012) 0.78

In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur? Int J Antimicrob Agents (2006) 0.78

The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance. Sex Health (2012) 0.78

Predominance of VREfm ST203 subgroup in Queensland. Pathology (2013) 0.77

Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children. J Paediatr Child Health (2010) 0.77

Community-associated methicillin-resistant Staphylococcus aureus causing orbital cellulitis in Australian children. Pediatr Infect Dis J (2011) 0.76

Hyperlactatemia in critical illness and cardiac surgery. Crit Care (2010) 0.76

Spatial analysis of community-onset Staphylococcus aureus bacteremia in Queensland, Australia. Infect Control Hosp Epidemiol (2013) 0.75

Melioidosis in south-eastern Queensland. Med J Aust (2009) 0.75

Inducible clindamycin resistance in erythromycin-resistant, non-multiresistant, methicillin-resistant Staphylococcus aureus. Pathology (2004) 0.75

A comparative assessment of two conservative methods for the diagnosis of catheter-related infection in critically ill patients. Intensive Care Med (2012) 0.75